By:
Published: January, 2005
DAY ONE: JANUARY 27, 2005
Plenary Session I – Goals of the MMA and Congressional Outlook in 2005
Newt Gingrich, Founder, Center for Health Transformation, Former Speaker (1994-1998), U.S. House of Representatives, and Author, Winning the Future: A 21st Century Contract with America
A webcast of this session is available at www.kaisernetwork.org as a free service of the Kaiser Family Foundation. Along with the webcast, a transcript and related resources will also be available.
Concurrent Session I – The Medicare Prescription Drug Benefit
Implementing the New Benefit. What are the issues? Who will participate? How will employers respond?
Martha Priddy Patterson, Director, Employee Benefits Policy Analysis, Deloitte Consulting
Employer Reactions to Medicare Part D – 2005 Survey Data
The Law Meets the Real World. What will the formularies look like? What role will pharmacy benefit managers (PBMs) play? What cost containment strategies will be used?
Robert Atlas, Independent Consultant and Former President, The Lewin Group
Practical Issues for PBMs in Medicare Part
Barrett Toan, Chairman and CEO, Express Scripts
The Medicare Prescription Drug Benefit and PBMs
Drug Reimportation. What are the potential effects on price and supply? How will safety issues be addressed? Is it the long-term answer?
Wayne Critchley, Executive Director, Patented Medicine Prices Review Board (Canada)
Drug Prices in Canada and the US: More than Meets the Eye?
Patricia Danzon, Celia Z. Moh Professor, The Wharton School, University of Pennsylvania
Drug Importation in the US: Lose-Lose for US and Foreign Consumers
Plenary Session II – New Survey Results on Beneficiaries’ Attitudes Toward Medicare
Drew Altman, President and CEO, Henry J. Kaiser Family Foundation
The MMA: On the Road to Implementation
A webcast of this session is available at www.kaisernetwork.org as a free service of the Kaiser Family Foundation. Along with the webcast, a transcript and related resources will also be available.
Concurrent Session II – Key Issues in the MMA
Challenges of Serving Low-Income Beneficiaries. What is the impact of the new drug benefit on dual eligibles? How will SSA/State Medicaid agencies work on enrollment?
Robert Hayes, President, The Medicare Rights Center
The Part D Benefit: Casualties Coming?
Cindy Parks Thomas, Senior Scientist, Schneider Institute for Health Policy, Brandeis University
Challenges of Serving Low-Income Beneficiaries: Impact of Cost Sharing
Health Savings Accounts (HSAs). What is the anticipated effect? How will they be implemented in FEHBP? Should HSAs get the discounts proposed for the uninsured?
Roy Ramthun, Senior Advisor for Health Initiatives, U.S. Department of the Treasury
All about HSAs
Karen Davis, President, The Commonwealth Fund
High Deductible Health Plans and Health Savings Accounts: For Better or Worse?
Charles Klippel, Senior Vice President and Deputy General Counsel – Health, Aetna
Health Savings Accounts and Trends in Employee Health Benefits
Plenary Session III – The Future of Medicare Advantage
Robert Berenson, MD, Senior Fellow, The Urban Institute
The Future of Private Plan Contracting In Medicare – A Reprise
Jack Ebeler, President and CEO, Alliance of Community Health Plans
The Future of Medicare Advantage
Marsha Gold, Senior Fellow, Mathematica Policy Research
The Future of Medicare Advantage: Will Past Be Prologue?
A webcast of this session is available at www.kaisernetwork.org as a free service of the Kaiser Family Foundation. Along with the webcast, a transcript and related resources will also be available.
DAY TWO: JANUARY 28, 2005
Plenary Session IV – The Future of Medicare What is the impact of the MMA? What is the outlook for social insurance programs? How will the prescription drug program affect Medicare’s standing as a social insurance program? What role should technology have in transforming Medicare?
A webcast of this session is available at www.kaisernetwork.org as a free service of the Kaiser Family Foundation. Along with the webcast, a transcript and related resources will also be available.
Concurrent Session III – Medicare Issues
Next Generation of Cost Containment. Can market-based strategies deliver? What lessons can be learned from past Medicare competitive pricing demonstrations for health plans and durable medical equipment? What are the costs (political and administrative) of implementing competitive arrangements?
Nancy-Ann DeParle (moderator), Senior Advisor, JPMorgan Partners, LLC and Former Administrator (1997–2000), Health Care Financing Administration (now CMS)
Medicare’s Long-Term Spending and Financing
Joseph Antos, Wilson H. Taylor Scholar in Health Care and Retirement Policy, American Enterprise Institute
Is There a Better Way to Reduce Growth in Medicare Spending?
Bill Scanlon, Health Policy Consultant
Improving the Environment for Competition: More Efficient Purchasing in Traditional Medicare
Disease Management. How successful have disease management efforts been so far? What is their real potential? How do you move from a single disease focus to the reality of multiple chronic conditions? What is the role of vendors, physicians, others?
Christopher Coloian, Vice President, Disease Management, CIGNA
Experience with Disease Management in the Commercial Sector
Sandra Foote, Director, Chronic Care Improvement Program, Centers for Medicare & Medicaid Services (CMS)
Update on Medicare Chronic Care Improvement Programs
Educating Beneficiaries. What strategies really work? How do you deal with low health literacy? How do you explain the complexity of the program in a way that is understandable to beneficiaries? How do you overcome language barriers?
Judith Hibbard, Professor, Department of Planning, Public Policy & Management, University of Oregon
Beneficiary Decision-Making & the New Prescription Drug Benefit
Michael McMullan, Deputy Director, Center for Beneficiary Choices, Centers for Medicare & Medicaid Services (CMS)
Medicare Modernization Act “Medicare & You” Education Campaign
Tricia Neuman, Vice President and Director, Medicare Policy Project, Henry J. Kaiser Family Foundation
Medicare Prescription Drug Benefit: Educating Beneficiaries
Plenary Session V – Reflections on Implementing the MMA
Mark McClellan, M.D., Administrator, Centers for Medicare & Medicaid Services (CMS)
A webcast of this session is available at www.kaisernetwork.org as a free service of the Kaiser Family Foundation. Along with the webcast, a transcript and related resources will also be available.
dddddddddddddddddd